Everest Medicines Announces NEFECON®, the World’s First Approved Treatment for IgA Nephropathy, is Included in China’s National Reimbursement Drug List
SHANGHAI, Nov. 28, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that NEFECON
Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market
MUMBAI, India, Nov. 28, 2024 /PRNewswire/ — The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national and international travel, particularly among Indian passengers. This surge has created a significant demand for relevant and regional conte
Antengene Announces XPOVIO®’s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country
SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medi
Sunmei Hotels Group Ventures into the UAE: SHANKEE to Open in Dubai
QINGDAO, China, Nov. 28, 2024 /PRNewswire/ — On November 26, the China Hotel Overseas Investment Conference, hosted by Sunmei Hotels Group, was successfully held at Mövenpick by Accor Qingdao Sunmei. During the conference, Sunmei Hotels Group announced the establishment of Sunmei Group Inter
Starlink Program | CoinEx Charity Deploys the First Starlink Unit to the Philippines
HONG KONG, Nov. 27, 2024 /PRNewswire/ — CoinEx Charity has successfully deployed the first Starlink satellite internet in the Philippines, marking a major milestone in connecting underserved communities to the digital world. Starlink Program, the flagship project of CoinEx Charity’s &#
Akeso Announced the Inclusion in China’s National Reimbursement Drug List of Cadonilimab and Ivonescimab
HONG KONG, Nov. 27, 2024 /PRNewswire/ — Akeso, Inc. (9926. HK) (“Akeso” or the “Company”) is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific antibody) and ivonesci
Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders
HANGZHOU, China, Nov. 28, 2024 /PRNewswire/ — The Second Liangzhu Forum, an assembly of global cultural experts, commenced in Hangzhou, Zhejiang Province on November 25, 2024. This year’s forum, under the theme “Exchange and Mutual Enlightenment, and New Forms of Human Civilization
Global Times: Dialogue across Yangtze, Rhine, Danube bridges mutual learning between China and Europe
BEIJING, Nov. 27, 2024 /PRNewswire/ — When Chinese scholar Li Xiuzhen first saw the Rhine River while studying in the Netherlands in 1996, she was deeply impressed by the river’s crystal-clear waters, similar to that of China’s Yangtze River. Although Li had never seen the Rhine b
ACT21 Software Achieves Great Place To Work Certification
NOIDA, India, Nov. 28, 2024 /PRNewswire/ — ACT21, a leading SaaS company reshaping BFSI tech with low-code, and AI-driven solutions is proud to announce that it has been awarded the esteemed Great Place To Work® Certification™ by the Great Place To Work® India. This significant recognitio
XREX CISO Leads DeFiHackLabs To Victory at SCAN 2024, the World’s First Digital Asset Tracking Challenge
SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ — DeFiHackLabs, a cutting-edge Web3 cybersecurity community backed by XREX Group and founded by its Chief Information Security Officer (CISO) Sun Huang, has taken first place at SCAN 2024, the world’s first digital asset tracking competition
